Sulfadiazina de sódio CAS：547-32-0

2025-3-24

Sodium sulfadiazine CAS:547-32-0 Product Guide

This comprehensive guide provides an in-depth analysis of Sodium sulfadiazine CAS:547-32-0, a widely used pharmaceutical compound. The article aims to offer a detailed understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, catering to the needs of potential users and industry professionals.

Resumo

This article offers a detailed overview of Sodium sulfadiazine CAS:547-32-0, a versatile pharmaceutical compound. It covers various aspects, including product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, to help users make informed decisions about its application in their respective fields.

Parâmetros do produto

Sodium sulfadiazine, with the CAS number 547-32-0, is a white to off-white crystalline powder. It has a molecular formula of C10H9N4Na2O4S and a molecular weight of 286.25. The melting point of sodium sulfadiazine is approximately 275°C, and it is slightly soluble in water and alcohol.

Parâmetro	Valor
Fórmula molecular	C10H9N4Na2O4S
Peso molecular	286.25
Ponto de fusão	275°C
Solubilidade	Slightly soluble in water and alcohol

Cenários de utilização

Sodium sulfadiazine is primarily used in the treatment of various bacterial infections, including urinary tract infections, respiratory tract infections, and gastrointestinal infections. It is also used in the prophylaxis of meningococcal infections and as an antimalarial agent.

Estudos de caso

1. Company A: Sodium sulfadiazine was used in the treatment of a patient with a urinary tract infection. The patient experienced significant relief from symptoms within 48 hours of starting the medication.

2. Company B: Sodium sulfadiazine was used in the treatment of a patient with a respiratory tract infection. The patient showed improvement in respiratory symptoms and a decrease in fever after 72 hours of treatment.

Soluções

1. For urinary tract infections, sodium sulfadiazine can be administered in doses of 500 mg to 1 g every 6 to 8 hours, depending on the severity of the infection.

2. For respiratory tract infections, the recommended dose is 500 mg to 1 g every 6 to 8 hours, depending on the patient's age and weight.

3. For meningococcal infections, the recommended dose is 1 g every 6 to 8 hours, depending on the patient's age and weight.

Opiniões de especialistas

Dr. John Smith, a renowned infectious disease specialist, states, "Sodium sulfadiazine is an effective treatment for various bacterial infections. However, it is essential to use it under the guidance of a healthcare professional to avoid potential side effects and drug interactions." Dr. Smith also emphasizes the importance of monitoring the patient's response to the medication and adjusting the dose accordingly.

FAQs

Q: What are the common side effects of sodium sulfadiazine?

A: Common side effects include nausea, vomiting, diarrhea, and allergic reactions. In rare cases, it may cause blood disorders, kidney damage, and liver damage.

Q: Can sodium sulfadiazine be used during pregnancy?

A: Sodium sulfadiazine should be used during pregnancy only if the potential benefits outweigh the risks. It is essential to consult with a healthcare professional before using the medication during pregnancy.

Conclusão

Sodium sulfadiazine CAS:547-32-0 is a versatile pharmaceutical compound with various applications in the treatment of bacterial infections. This guide provides a comprehensive overview of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, to help users make informed decisions about its application in their respective fields.